The Culture of Business
Just like in line with our city’s vision in the SA2020 plan, more innovation in bioscience and healthcare is happening right here in our city, innovation that could save lives on the battlefield.
Story via the San Antonio Business Journal:
Vidacare Corp. has been given the green light to begin marketing a new product that could save a significant number of lives in war zones.
That approval, granted recently by the Food and Drug Administration, will give the San Antonio-based company an opportunity to expand its revenue opportunities as the medical device industry prepares to take a hit from a new tax that will be levied with the roll-out of the Affordable Care Act.
The Tactically Advanced Lifesaving Intraosseous Needle, or TALON, is a variation of Vidacare’s core product, the EZ-IO, a drill-driven needle system used by an assortment of medical professionals to access the vascular system via the bone in order to deliver vital fluids and drugs.
Unlike the EZ-IO, the TALON is a manually-operated device that is lighter in weight and more compact, features which are critical for medics in a combat arena.
“The military wanted an alternative (device) for the battlefield,” says Vidacare President and CEO Mark Mellin. “That’s what this is. There is no other product out there like this.”
Medical device manufacturers are required by the FDA to submit a premarket notification if they intend to introduce a device into commercial distribution for the first time or to reintroduce a device that will be significantly changed or modified.
Vidacare has received the necessary FDA clearance for the TALON and plans to introduce the device commercially next month.
For more information on the bioscience and healthcare industry sector in San Antonio visit http://www.biomedsa.org